C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.

scientific article

C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AMJCARD.2005.11.060
P698PubMed publication ID16635602

P50authorFrancesco VersaciQ46000244
Achille GaspardoneQ90007264
Fabrizio TomaiQ118957129
P2093author name stringIgino Proietti
Olga Skossyreva
Gaetano Gioffrè
Carlo Citone
P433issue9
P407language of work or nameEnglishQ1860
P304page(s)1311-1316
P577publication date2006-03-20
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleC-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.
P478volume97

Reverse relations

cites work (P2860)
Q58471428A transthoracic Doppler echocardiography study of C-reactive protein and coronary microcirculation in children after open heart surgery
Q37362731Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
Q39240862Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina
Q88535298Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease
Q51036735Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study.
Q37709401Predictive value of C-reactive protein after drug-eluting stent implantation
Q28548500Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation
Q35954252Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation
Q54655905Serum inflammatory and immune marker response after bare-metal or drug-eluting stent implantation following percutaneous coronary intervention.
Q41909214Stent hypersensitivity and infection in sinus cavities
Q84535196Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting
Q39050235The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention.

Search more.